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Abstract
Objective: Little is known about the trajectory of health and well-being from before to after a cancer
diagnosis. This study aimed to examine changes in health andwell-being across three time points (0–2 years
before a cancer diagnosis, 0–2 years post-diagnosis and 2–4 years post-diagnosis) in individuals receiving
a new cancer diagnosis, and at matched time points in a cancer-free comparison group.
Methods: Data were from waves 1–6 of the English Longitudinal Study of Ageing. Repeated-
measures ANOVAs were used to examine differences in self-rated health, mobility impairments,
activities of daily living impairments, quality of life, depressive symptoms and life satisfaction by
group and time, and group-by-time interactions.
Results: Of the 4565 participants with data from three time points, 444 (9.7%) reported a new can-
cer diagnosis. Those in the cancer group reported poorer self-rated health (p< .001), quality of life
(p< .001) and life satisfaction (p< .01) than participants in the comparison group, and a higher pro-
portion reported depressive symptoms (p< .001) and impairments in mobility (p< .001) and activities
of daily living (p< .001). All markers of health and well-being worsened signiﬁcantly over time. The
group-by-time interaction was signiﬁcant for self-rated health (p< .001), with a greater decline in
health over time in the cancer group.
Conclusions: Cancer survivors in this sample had poorer health and well-being than those with no
diagnosis, and self-rated health deteriorated more rapidly following a cancer diagnosis. Screening
for these factors around the time of a cancer diagnosis could allow for interventions to be targeted
effectively and improve the health and well-being of cancer survivors.
© 2015 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Background
There are now an estimated 36.2 million cancer survivors
worldwide [1,2]. This has led to increasing research atten-
tion on optimising the well-being, health and survival of
those living beyond a diagnosis of cancer.
Population-based studies have typically found that
cancer survivors have poorer quality of life [3,4], more
anxiety [5] and depressed mood [4]; have more limitations
of activities of daily living (ADL) [6] and report poorer
health [6,7] than those without a diagnosis of cancer. They
also have greater use of mental health services [8]. In the
UK, cancer survivors have been found to experience
poorer health and well-being across a wide range of out-
comes than individuals with a chronic condition other than
cancer [9].
Very few longitudinal studies have examined changes
in health and well-being following a cancer diagnosis.
One compared 206 cancer survivors with 120 healthy
age-matched controls at 3 months, 15 months and 8 years
post-cancer diagnosis [10]. Compared with the healthy
comparison group, cancer survivors experienced more
physical symptoms and these persisted at the 8-year
follow-up. They had more depressive symptoms at
3 months, although differences were no longer signiﬁcant
at 15 months or 8 years post-diagnosis. These ﬁndings
suggest that some of the adverse effects may diminish
over time. In contrast, another study found that 10 years
post-diagnosis, breast cancer survivors not only experi-
enced poorer physical and social functioning than con-
trols, but that these differences increased in the long
term [11], suggesting that health and well-being may be
affected for many years after a cancer diagnosis.
None of the studies to date have included pre-diagnosis
data, making it is difﬁcult to determine if the health and
well-being effects are a direct consequence of their cancer
diagnosis. The acute impact of cancer diagnosis and treat-
ment may cause health and well-being to deteriorate, but
some of the differences may be long-standing. Therefore,
the aim of study was to examine the trajectory of health
and well-being from pre-cancer diagnosis to multiple
times post-diagnosis, in order to determine how health
and well-being change following a cancer diagnosis, and
whether they return to pre-diagnosis levels. Speciﬁcally,
it examined the effect of a cancer diagnosis on changes
in health and well-being from 0 to 2 years before a cancer
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diagnosis, through 0–2 and 2–4 years after diagnosis,
using data from a population-based sample of older adults
in the UK. The comparison sample comprised all people
who did not receive a diagnosis of cancer, regardless of
other diagnoses, in order to examine the speciﬁc inﬂuence
of a cancer diagnosis, over and above the range of health
conditions that affect people at older ages.
Methods
Design and participants
Data were from waves 1–6 of the English Longitudinal
Study of Ageing (ELSA), which were collected at two
yearly intervals between 2002 and 2012. Details on the
cohort and sampling method have been published else-
where [12], but brieﬂy, ELSA is a panel study recruited
from households with one or more members aged
≥50 years responding to the Health Survey for England
in 1998, 1999 and 2001 (core sample: n=12 099), with
‘refreshment samples’ added from additional rounds of
the Health Survey for England in 2006, 2008 and 2012.
Participants are followed up every 2 years, where they
complete a computer-assisted personal interview during
a home visit and a self-completed questionnaire that is
returned by post. The present study uses data on health
and well-being from participants reporting a new cancer
diagnosis in any of waves 2 to 5 and control participants
who were cancer-free at all six waves. ELSA has received
approval from various ethics committees, including the
London Multi-Centre Research Ethics Committee, and
full informed consent has been obtained from all
participants.
The analysed sample included participants who re-
ported a new cancer diagnosis in waves 2 to 5 and had
provided data at both the previous and subsequent wave.
The ﬁrst wave in which a cancer diagnosis was reported
became the ‘peri-diagnosis’ point (T1), the previous wave
was the ‘pre-diagnosis’ point (T0) and the subsequent
wave was the ‘post-diagnosis point’ (T2). Individuals
reporting a cancer diagnosis at wave 1 or a new diagnosis
at wave 6 were excluded from the analysis because of the
absence of pre-diagnosis or post-diagnosis data respec-
tively. Likewise, participants from a refreshment cohort
reporting a cancer diagnosis on joining the study were ex-
cluded for the same reason.
The comparison group comprised participants who had
not received a cancer diagnosis in any wave. This was
favoured over a completely healthy control group (as used
in some studies) because it enabled us to determine the
speciﬁc inﬂuence of a cancer diagnosis, over and above
any other chronic diseases. To match the time points used
for the cancer survivor group, for continuous variables, we
used the mean of all possible pre-diagnosis waves for T0
(waves 1 to 4), the mean of all possible peri-diagnosis
waves for T1 (waves 2 to 5) and the mean of all possible
post-diagnosis waves for T2 (waves 3 to 6); giving an
average interval of 2 years between each time point. For
categorical variables, we calculated mean scores following
the same method and dichotomised these scores at the
relevant cut-point.
For both the cancer survivor and comparison groups,
we only included individuals with data on at least one out-
come variable at all three time points (T0, T1 and T2).
Measures
Cancer diagnosis
A cancer diagnosis was deﬁned as answering ‘yes’ to the
question: ‘Have you ever been told by a doctor or other
health professional that you had cancer or any other kind
of malignancy’. If they said yes they were asked ‘In which
part of body did the cancer/cancers/malignant tumor
start’ with response options: lung/breast/colon, bowel or
rectum, lymphoma/leukaemia/melanoma or other skin
cancer/somewhere else. For these analyses, we included
all cancers combined.
Demographic characteristics
Age and sex were included as control variables. House-
hold non-pension wealth used as an indicator of socio-
economic status, as it has been identiﬁed as particularly
appropriate to this age group [13].
Co-morbidities
The presence of co-morbidities was assessed with the
question: ‘Has a doctor ever told you have any of the fol-
lowing conditions…coronary heart disease (CHD), diabe-
tes, arthritis, asthma, stroke, chronic lung disease and
hypertension’ [select all that apply].
Health and quality of life
Self-rated health was assessed using a single item: ‘Would
you say your health is… poor/fair/good/very good/
excellent?’ Scores ranged from 1 to 5 with higher scores
indicating better self-rated health.
Mobility was assessed by asking participants if they had
any difﬁculty performing 10 everyday activities because
of a health problem (excluding any that they expected to
last less than three months). Activities included walking
100 yards, sitting for about 2 h and getting up from a chair
after sitting for long periods. A binary (yes/no) response
format was used, with scores ranging from 0 to 10 accord-
ing to the number of activities with which a difﬁculty was
reported. Because the resulting summary scores were
highly skewed, with most participants reporting no difﬁ-
culty performing any activities, we created a dichotomous
variable with a score of 1 or more identifying participants
with any mobility impairment.
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Activities of daily living (ADLs) were assessed by
asking participants if they had difﬁculty performing six
everyday activities because of a health or memory prob-
lem (excluding any that they expected to last less than
three months). Activities included bathing or showering,
preparing a hot meal and shopping for groceries. A binary
(yes/no) response format was used, with scores ranging
from 0 to 6 according to the number of activities with
which a difﬁculty was reported. Scores were dichotomised
to distinguish between participants reporting any ADL
impairment (score of 1 or more) and those with no ADL
impairment (score of 0).
Quality of life was assessed using the CASP-19, a vali-
dated measure developed speciﬁcally to assess quality of
life in early old age [14]. It contains 19 items on four
sub-domains: control, autonomy, pleasure and self-
realisation. Respondents indicate their agreement with
each statement, for example: ‘my age prevents me from
doing things I would like to do’, on a 4-point Likert scale
from 0 (never) to 3 (often). Total scores ranged from 0 to
57 with higher scores indicating higher quality of life.
Psychological well-being
Depressive symptoms were assessed using an 8-item ver-
sion of the Center for Epidemiologic Depression Scale
[15]. Respondents were asked to indicate if they had expe-
rienced depressive symptoms (e.g. restless sleep and being
unhappy) over the past month using a binary (yes/no) re-
sponse. Total scores ranged from 0 to 8 with higher scores
indicating more depressive symptoms. Data were highly
skewed, so we dichotomised scores using an established
cut-off, with a score of 4 or higher indicating the presence
of depressive symptoms [16].
Life satisfaction was assessed using the Satisfaction
with Life Scale [17]. Respondents are asked to indicate
their agreement with ﬁve statements, for example: ‘In
most ways my life is close to my ideal’, on a 7-point Likert
scale from 0 (strongly disagree) to 6 (strongly agree).
Total scores ranged from 0 to 30 with higher scores indi-
cating greater life satisfaction. Life satisfaction was not
assessed in wave 1 of ELSA, so analyses were restricted
to participants with new cancer diagnoses in waves 3 to
6, with scores from waves 2 to 6 used to create means
for the comparison group.
Statistical analyses
Demographic characteristics and co-morbidities of the two
groups were compared using t-tests for continuous vari-
ables and chi-squared analyses for categorical variables.
Repeated-measures analyses of variance (ANOVAs) (con-
tinuous variables) and generalised estimating equations
(categorical variables) were used to examine main effects
of group (overall group differences in self-rated health,
mobility impairments, ADL impairments, quality of life,
depressive symptoms and life satisfaction independent of
time), main effects of time (changes in health and well-
being over time independent of group) and group-by-time
interactions (differences in changes in health and well-
being over time between groups). Age, sex and wealth
were entered as covariates for all analyses.
Results
Demographic characteristics
The characteristics of the 4565 participants, comprising
444 (9.7%) who received a cancer diagnosis and 4121 in
the comparison group are shown in Table 1. Of the 444
cancer diagnoses, 3% (n=12) were lung cancer, 20%
(N=89) were breast cancer, 16% (N=69) were colorectal
cancer, 21% (N=91) were skin cancer, and 41%
(n=183) had another cancer. Those in the cancer group
were older (67.4 vs 65.0; p< .001), and more of them
were male (49.8% vs 43.8%, p< .05), but the groups did
not differ by wealth (p= .359). Compared with the com-
parison group, those in the cancer group were more likely
to have been diagnosed with CHD (21% vs. 12%,
p< .001), diabetes (23% vs. 14%, p< .001), arthritis
(59% vs. 52%, p< .01), stroke (13% vs. 7%, p< .001)
and chronic lung disease (14% vs. 10%, p< .01). There
were no differences for asthma or hypertension.
Health and quality of life
Figure 1 shows the mean self-rated health of each group at
each time. Participants in the cancer group had worse self-
rated health (p< .001) and overall, self-rated health de-
creased over time (p< .001). Between T0 and T1, mean
self-rated health scores dropped from 3.45 to 2.84 in the
cancer group and from 3.67 to 3.46 in the comparison
group. Between T1 and T2, mean self-rated health in-
creased slightly from 2.84 to 2.98 in the cancer group
and fell from 3.46 to 3.39 in the comparison group. The
group-by-time interaction was signiﬁcant (p< .001),
Table 1. Demographic characteristics of sample—percentage (n),
mean (SD)
Characteristics
Cancer group
(n = 444)
Comparison group
(n = 4121) p
Age 67.36 (9.00) 65.04 (8.54) <.001
Sex
Male 49.8% (221) 43.8% (1806)
Female 50.2% (223) 56.2% (2315) .016
Wealth quintiles
1 (lowest) 12.4% (55) 12.9% (531)
2 16.9% (75) 17.8% (733)
3 24.1% (107) 20.4% (839)
4 20.5% (91) 23.3% (960)
5 (highest) 26.1% (116) 25.7% (1058) .359
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indicating a greater decline in self-rated health over time
in the cancer group compared to the comparison group.
Figure 2 shows the proportion of participants with mo-
bility impairments for each group at each time. A greater
proportion of the cancer group had mobility impairments
(p< .001) and overall, the proportion with mobility im-
pairments rose over time (p< .001). Between T0 and T1,
the proportion of participants with mobility impairments
increased from 60 to 65% in the cancer group and from
49 to 52% in the comparison group. Between T1 and
T2, the proportion with mobility impairments increased
from 65 to 67% in the cancer group and from 52 to 54%
in the comparison group. The group-by-time interaction
was not signiﬁcant (p=.572).
Figure 3 shows the proportion of participants with ADL
impairments for each group at each time. A greater pro-
portion of the cancer group had ADL impairments
(p< .001). The proportion with ADL impairments in-
creased over time (p< .001). Between T0 and T1, the pro-
portion of participants with ADL impairments increased
from 21 to 23% in the cancer group and from 11 to 12%
in the comparison group. Between T1 and T2, the
proportion with ADL impairments increased from 23 to
29% in the cancer group and from 12 to 14% in the com-
parison group. The group-by-time interaction was not sig-
niﬁcant (p= .330).
Figure 4 shows the mean total CASP-19 scores for each
group at each time. Those in the cancer group had signif-
icantly lower quality of life (p< .001), and overall, scores
decreased over time (p< .001). Between T0 and T1,
scores fell from 42.2 to 41.3 in the cancer group and from
44.0 to 43.5 in the comparison group. Between T1 and T2,
scores fell from 41.3 to 40.7 in the cancer group and from
43.5 to 42.5 in the comparison group. The group-by-time
interaction was not signiﬁcant (p= .126).
Psychological well-being
Figure 5 shows the proportion of participants with depres-
sive symptoms in each group at each time. A greater pro-
portion of the cancer group had depressive symptoms
(p< .001). Overall, the proportion with depressive symp-
toms increased and then declined over time (p= .027).
Between T0 and T1, the proportion of participants with
Figure 1. Mean self-rated health (with 95% conﬁdence intervals)
for each group at each time point (adjusted for age, sex and wealth)
Figure 2. Proportion with mobility impairments (with 95% conﬁ-
dence intervals) in each group at each time point (adjusted for
age, sex and wealth)
Figure 3. Proportion with ADL impairments (with 95% conﬁdence
intervals) in each group at each time-point (adjusted for age, sex and
wealth)
Figure 4. Mean quality of life (with 95% conﬁdence intervals) for
each group at each time point (adjusted for age, sex and wealth)
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depressive symptoms rose from 15 to 19% in the cancer
group and did not change in the comparison group (7%).
Between T1 and T2, the proportion of participants with de-
pressive symptoms dropped from 19 to 17% in the cancer
group and did not change in the comparison group. This
group-by-time interaction was not signiﬁcant (p= .084).
Figure 6 shows the mean total life satisfaction scores for
each group at each time. Those in the cancer group had
signiﬁcantly lower life satisfaction (p< .01). Overall, life
satisfaction reduced and then increased over time
(p< .001). Between T0 and T1 scores dropped from
19.9 to 19.8 in the cancer group and from 21.0 to 20.9
in the comparison group. Between T1 and T2, scores rose
from 19.8 to 20.0 in the cancer group and from 20.9 to
21.0 in the comparison group. The group-by-time interac-
tion was not signiﬁcant (p= .937).
Discussion
This study investigated the impact of a cancer diagnosis
on health and well-being in a population-based sample
of older adults living in England. At all time points, those
with a diagnosis of cancer reported poorer self-rated
health, quality of life and life satisfaction than those with
no diagnosis, and a higher proportion reported depressive
symptoms and impairments in mobility and ADL. In both
groups, all markers of health and well-being worsened sig-
niﬁcantly over time, with the exception of depressive
symptoms. Those with a cancer diagnosis showed a
greater decline in self-rated health over time compared
with the comparison group.
Cancer survivors reported being in worse health than
those with no diagnosis, consistent with previous reports
of poor health in this population [6,7]. This was also the
case before their cancer diagnosis, which may be attrib-
uted to them experiencing potential signs and symptoms
of cancer in the lead up to their diagnosis. Around the time
of their diagnosis, they reported a greater reduction in
their health, which is unsurprising given that they had
been given a serious diagnosis. Although their self-
reported health recovered slightly a couple of years later,
it did not returned to pre-diagnosis levels, consistent with
reports that physical symptoms can persist for many years
following a cancer diagnosis and highlighting the impact
of the long-term effect of cancer [10].
We found that cancer survivors experienced more de-
pressive symptoms than those without a cancer diagnosis
[4]. This is in line with previous studies, which have
shown that as many as 58% of cancer survivors may re-
port depressive symptoms [18]. Interestingly, this was
also the case before their cancer diagnosis, suggesting
that impaired well-being may begin several months or
even years before the diagnosis of cancer. Future research
could explore how long before a diagnosis individuals
start to show such impairments. However the proportion
of individuals experiencing depressive symptoms in-
creased over time in both groups, suggesting that a cancer
diagnosis does not have a particularly speciﬁc impact on
the experience of depressive symptoms. However, there
was a non-signiﬁcant spike in the proportion of those
experiencing depressive symptoms in the cancer group
around the time of diagnosis, highlighting the potential
adverse effect of a cancer diagnosis. Similar to previous
studies [10], the proportion of cancer survivors
experiencing depressive symptoms appeared to drop
slightly over time although it remained higher than both
pre-diagnosis levels and the comparison group. These
ﬁndings highlight the importance of psychological assess-
ment in this population.
A greater proportion of cancer survivors had impair-
ments in mobility or ADL, similar to ﬁndings from
cross-sectional studies [6]. Again, this was also the case
before their cancer diagnosis, suggesting that cancer
may begin to affect functioning even before a diagnosis
is made. This may be a direct consequence of a cancer
diagnosis but it could also be due to long-standing
Figure 5. Proportion with depressive symptoms (with 95% conﬁ-
dence intervals) in each group at each time point (adjusted for
age, sex and wealth)
Figure 6. Mean life satisfaction (with 95% conﬁdence intervals) for
each group at each time point (adjusted for age, sex and wealth)
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characteristics, such as poorer health behaviours. The
proportion of those experiencing ADL and mobility im-
pairments increased across the three time points by
roughly the same degree in both groups. Although this
suggests that a cancer diagnosis itself did not have a sub-
stantial impact on impairments, it is consistent with a
previous study that showed a decline in physical and
social functioning between 5 and 8 years post-cancer di-
agnosis [11].
Those who received a diagnosis of cancer had poorer
quality of life and lower life satisfaction than those with
no diagnosis, similar to previous studies [3,4,9]. This
was also the case at the pre-diagnosis time point, suggest-
ing that well-being may be affected by cancer even be-
fore a diagnosis is made. This may be due to the
undiagnosed cancer making them feel unwell and thus
impacting on their psychological well-being, although it
could also be related to the same long-standing character-
istics that also cause this group to have more mobility
and ADL impairments. There was a change in quality
of life and life satisfaction over the three time points
but this did not differ by group, suggesting that a cancer
diagnosis does not adversely affect these aspects of well-
being. However, even not triggered by the cancer diagno-
sis, quality of life declined over time and remained worse
in the cancer group, highlighting an opportunity of
psychological intervention.
This study had a number of limitations. The cancer data
were self-reported, and it is possible that people may not
have reported a diagnosis that was a long time ago, or they
may have reported having cancer if they were diagnosed
with a benign tumour. We did not have the exact date of
diagnosis; which could have been any time from just after
T0 or just before T1 (a range of 2 years). It is therefore
possible that there may have been short-term changes in
health and well-being that were not captured by this study.
The sample size was not large enough to analyse by can-
cer site, and it is possible that the effects would have been
different for diagnoses where prognosis was better or
worse, or where treatment was more or less damaging.
Our analyses only included individuals with three waves
of data and as a result, those who died or elected not to
take part any longer were excluded.
In conclusion, we found that cancer survivors were
worse off those with no diagnosis on all aspects of
health and well-being. Interestingly, cancer survivors
were more impaired in several of these domains even
before their diagnosis was made. Screening for these
factors around the time of a cancer diagnosis could
allow for interventions to be targeted effectively and
improve the health and well-being of cancer survivors.
We also found that a cancer diagnosis had an adverse
effect on self-rated health which continued to deteriorate
at a greater rate than controls over time. Ensuring that
people diagnosed with cancer receive appropriate psy-
chological support could help minimise the impact of a
diagnosis.
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